Answers are grounded in this paper and cite their sources.
Among HIV-infected patients with advanced immunosuppression, enhanced antimicrobial prophylaxis combined with ART resulted in reduced rates of death at both 24 weeks and 48 weeks without compromising viral suppression or increasing toxic effects. (Funded by the Medical Research Council and others; REALITY Current Controlled Trials number, ISRCTN43622374 .).
No takes yet. Share an insight, caveat, or question.
Hakim et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: